SMS Lifesciences India

quarterly
yearly
ParticularsSep '22Dec '22Mar '23Jun '23Sep '23
Revenue81.4188.7966.1975.2669.60
Expenses77.3183.2366.1778.0067.94
EBITDA8.429.864.743.158.20
EBIT5.787.234.17-0.554.47
Profit Before Tax4.095.562.36-2.731.66
Net Profit3.123.822.11-3.83-0.44
Financial Ratios
Operating Profit Margin10.36%11.18%11.13%4.21%11.84%
Net Profit Margin3.38%4.52%1.10%-2.41%-1.60%
Earning Per Share (Diluted)9.1013.18-1.72-5.942.20
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.5.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ